Bio-Techne (TECH) Payables (2016 - 2026)
Bio-Techne has reported Payables over the past 16 years, most recently at $26.3 million for Q4 2025.
- For Q4 2025, Payables fell 20.69% year-over-year to $26.3 million; the TTM value through Dec 2025 reached $26.3 million, down 20.69%, while the annual FY2025 figure was $25.3 million, 33.34% down from the prior year.
- Payables for Q4 2025 was $26.3 million at Bio-Techne, down from $30.2 million in the prior quarter.
- Over five years, Payables peaked at $38.0 million in Q2 2024 and troughed at $24.1 million in Q4 2022.
- A 5-year average of $29.2 million and a median of $29.1 million in 2021 define the central range for Payables.
- Biggest five-year swings in Payables: surged 47.86% in 2024 and later plummeted 33.34% in 2025.
- Year by year, Payables stood at $26.8 million in 2021, then decreased by 9.93% to $24.1 million in 2022, then skyrocketed by 30.76% to $31.5 million in 2023, then grew by 5.1% to $33.1 million in 2024, then dropped by 20.69% to $26.3 million in 2025.
- Business Quant data shows Payables for TECH at $26.3 million in Q4 2025, $30.2 million in Q3 2025, and $25.3 million in Q2 2025.